InvestorsHub Logo
Followers 4
Posts 207
Boards Moderated 0
Alias Born 03/06/2022

Re: None

Thursday, 09/29/2022 1:33:48 PM

Thursday, September 29, 2022 1:33:48 PM

Post# of 459952
Does anybody here know when the recently released Eisai/Biogen Phase 3 AD study for Lecanemab was completed? I didn't see a date mentioned in the press release, and when I went to ClinicalTrials.gov there seemed to be nothing with a 2022 completion date. (There was one suspiciously similar that was labeled active with an estimated completion date of 9/15/2025, but perhaps this 18 mo. piece announced the other day was the "Core Study" and released prior to the conclusion of the whole trial?)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News